Table 1.
Characteristics of statin initiators identified in Medicare Part D claims, 2006–2011
| Claims-based Statin Initiators (n=766) |
||
|---|---|---|
| N | % | |
| Age, Mean (Std. Deviation) | 75.8 | (6.5) |
| Female | 483 | 63.1% |
| Race | ||
| White | 617 | 80.5% |
| Black | 80 | 10.4% |
| Other | 69 | 9.0% |
| Low-income Subsidy Recipient (LIS) |
191 | 24.9% |
| Healthcare Past 30 Days | ||
| 1+ Rx | 579 | 75.6% |
| 1+ Inpatient or Outpatient Visit |
404 | 52.7% |
| Comorbidities | ||
| Diabetes | 203 | 26.5% |
| Hypertension | 404 | 52.7% |
| Hyperlipidemia | 400 | 52.2% |
| Ischemic heart disease | 173 | 22.6% |
| Arterial fibrillation | 61 | 8.0% |
| Heart Failure | 93 | 12.1% |
| Acute Events | ||
| Myocardial infarction | 28 | 3.7% |
| Unstable angina | 27 | 3.5% |
| Stroke | 107 | 14.0% |
| Cardiovascular Disease Management |
||
| Angiography | 44 | 5.7% |
| Cardiac stress test | 76 | 9.9% |
| Echocardiograph | 134 | 17.5% |
| Lipid testing | 279 | 36.4% |
| Inpatient Stays | ||
| 0 Stays | 707 | 92.3% |
| 1 Stay | 44 | 5.7% |
| 2+ Stays | 15 | 2.0% |